An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Clinical trial NCT02776735 · COMPLETED
Trial details
- NCT number
- NCT02776735
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-06
- Primary completion
- 2022-04-08
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.